Dailypharm Live Search Close

[Reporter's View]Drugs fluctuating prices should be excluded

By Lee, Hye-Kyung | translator Choi HeeYoung

20.11.20 06:20:15

°¡³ª´Ù¶ó 0



The lawsuit for canceling eye drops¡¯ price ended with the Supreme Court's ruling. Recently, the Supreme Court did not accept the appeal of 20 pharmaceutical companies, including Kookje, filed against the government to cancel a lawsuit for canceling the disposition of lowering the upper limit on the reimbursement of eye drops. After the defeat of the Supreme Court by eight pharmaceutical companies including Daewoo in September, the government won all of the remaining trials.

The lawsuit for lowering the drug price for eye drops was conducted by pharmaceutical companies who opposed the enforcement of the government's notice in August 2018.
It started with a trial divided into Kookje and Daewoo. It

Lee, Hye-Kyung(hgrace7@dailypharm.com)
If you want to see the full article, please JOIN US (click)